An FDA advisory panel has rejected denosumab as treatment against bone metastasis in prostate cancer - http://bit.ly/xcYuTY
1:13 PM - 8 Feb 2012
0 replies
2 retweets
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.